KORU Medical Systems to Participate in Upcoming Investor Conferences
11 November 2022 - 8:01AM
Business Wire
KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the
“Company”), a leading medical technology company focused on the
development, manufacturing, and commercialization of innovative and
easy-to-use subcutaneous drug delivery systems that improve quality
of life for patients, today announced that the Company will
participate in two upcoming investor conferences.
KORU Medical's management is scheduled to present at the
Canaccord MedTech, Diagnostics and Digital Health & Services
Forum on Thursday, November 17th, 2022 at 11:30 am EST. Interested
parties can access the live and archived webcast on the News/Events
page of the Investors section of KORU Medical’s website at
www.korumedical.com.
KORU Medical's management will also be participating at the 13th
Annual Craig-Hallum Alpha Select Conference on Thursday, November
17th, 2022.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes
innovative and easy-to-use subcutaneous drug delivery systems that
improve quality of life for patients around the world. The FREEDOM
Syringe Infusion System currently includes the FREEDOM60® and
FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™
and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are
used for infusions administered in the home and alternate care
settings. For more information, please visit
www.korumedical.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221110005917/en/
Investor Contact: Greg Chodaczek 347-620-7010
investor@korumedical.com
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
KORU Medical Systems (NASDAQ:KRMD)
Historical Stock Chart
From Apr 2023 to Apr 2024